Enhanced Liver Fibrosis (ELF™) Test Gauges Likelihood of Disease Progression; Expands Labcorp’s Testing Options for Nonalcoholic Fatty Liver Disease The ELF test provides a numeric score to people ...

At present, transient elastography and the serum marker FibroTest are the most intensively evaluated non-invasive methods for the assessment of liver fibrosis. The results of the present study for ...

Early detection of individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) at risk of progression to advanced liver disease is crucial for intervention ...

Chronic liver disease poses a growing global health burden, driven in large part by metabolic risk factors and viral hepatitis. Fibrosis stage is the principal ...

Formerly known as NAFLD, or non-alcoholic fatty liver disease, MASLD affects about 30% of the world’s population, according to Roche. (eranicle/iStock/Getty Images Plus) Roche is rolling out a new ...

Hepta, a liquid biopsy company developing blood tests for chronic disease, today announced clinical data showing its blood test more accurately identifies metabolic dysfunction-associated ...

Combining retina scanning with liver stiffness assessment offers a promising, efficient approach to identify advanced fibrosis and MASLD in type 2 diabetes patients. Study: Screening for advanced ...

A new study finds that a blood test may be a more reliable indicator of liver disease than asking how much a person drinks. Excessive drinking can damage the liver. Yet, unlike obesity or high ...

If your diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) came as a surprise, you're not alone. Usually, you're diagnosed after a routine blood test shows higher than ...

A new blood test can detect a precursor to liver disease, which can in turn be a harbinger of cancer. The hope is that the test could help prevent liver cancer before it occurs. The test uses a ...